On the recordOctober 16, 2017
It's a penalty that affects generics in a different way than branded pharmaceuticals?
Source
congress.govEditor's note · Context
Senator Kaine questions the impact of penalties on generics versus branded drugs.
Share & report
More from Tim Kaine
Jun 22, 2025
We should not be sending troops, and risking troops' lives in an offensive war without a debate in Congress.
Jul 22, 2025
The Mexican government’s unfair targeting of Vulcan Materials Company, a U.S.-based company that employs over 1,000 people in Virginia, is harmful to the relationship between our two countries and severely undermines investor confidence.
Jun 19, 2025
A third war in the Middle East in this century would be a horrible, horrible mistake, and it's going to put U.S. service members at risk and also risk destabilizing the region.
Other voices in this conversation
